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Abstract 
 An analytical and clinical study has been applied for measure the bioavailability of Zinc in serum of twenty adults 
healthy volunteers, using flame atomic absorption spectrophotometer (FAAS) at 213.9 nm. The calibration graph is 
linear in the ranges of 0.25-1.5 µg.mL-1 with correlation coefficient (R) 0.09996)µg.mL1-and molar absorpitivites 
22957.76(L.mol1-cm-1.The concentration of Zinc determined in serum of all volunteers before and after 
administered orally a tablet of 50 mg zinc sulphate, produced by Samara drugs company (SDI). All data were 
subjected to statistical analysis by calculating accuracy, precision in addition to other parameters. The results 
indicate that the average maximum concentration (C-max ± SD) of blood zinc was 0.8275  ± 0.0511mg.mL-1after 
one hour of absorption (T-max ± SD), however one capsule has drug bioavailability through all day.     
Keywords: Analytical, Clinical, Bioavailability, Zinc, Flam atomic abortion. 
                                                                                                
1. Introduction: 
Zinc is an essential mineral for human cell growth, differentiation, and DNA synthesis (1). It is play a critical role 
in the development and maintenance of a healthy immune system (2). There are many associations with diarrhea 
and increased fecal zinc loss, negative zinc balance, and low tissue zinc concentrations (3). High zinc loss during 
diarrhea has been observed in infants )4,5) Zinc supplementation for the treatment of diarrhea may also be critical 
in improving overall immune function. Individual zinc deficiency is difficult to accurately assess. Population level 
estimates from national food balance sheets are able to determine the amount of bio-available zinc per person per 
day by country. These data estimate 21% of persons around the world are at risk of zinc deficiency )6). In 2002 the 
World Health Organization defined zinc deficiency as one of the major risks to child health (7). 
Zinc is nutritionally an essential element and is required for the activity of a number of enzymes. About 20-30% of 
the ingested zinc is absorbed. Within mucosal cells zinc forms metal-protein complexes. Its known to be essential 
trace elements and a component of hundred of enzymes (8). Toxicity consequent upon excessive intake of this 
metal is rather uncommon (9).      
   In recent years, the importance of zinc for human health and development (10) and the possible widespread 
occurrence of suboptimal zinc intakes (11,12) have gained recognition. The fortification of staple foods with zinc 
may play an important role in achieving adequate zinc intakes in at-risk populations. two of the most commonly 
used zinc fortificants to date are zinc oxide and zinc sulfate(13).a few earlier studies compared the absorption of 
zinc between these chemical forms using the oral zinc tolerance test as a measure of bioavailability, but the results 
were conflicting. One of those studies reported a much lower plasma appearance from zinc oxide preparations 
compared with zinc sulfate, whereas the other reported no difference. A more recent study used stable isotope tracer 
techniques to measure zinc absorption in a group of Indonesian children; in that study, wheat flour dumplings were 
fortified with either zinc oxide or zinc sulphate(14) and zinc absorption did not differ between groups. Zinc is an 
essential trace element   for humans and animals (15). The recommended daily allowance is 11 mg of zinc per day 
in diet of a human adult (16). Zinc deficiency produces profound physiological changes. Growth retardation, loss of 
taste acuity, skin ulcers, and sexual dysfunction has demonstrated in human studies as resulting from a deficiency 
of zinc. A deficiency is common in many diseases, including anemia, cancer and atherosclerosis.  Patients with 
rosacea who attended the outpatient Clinic of Dermatology and Venereology in Baghdad Teaching Hospital were 
recruited into this. A disease severity score was calculated for each patient. The patients were randomly allocated to 
receive either zinc sulfate 100 mg or identical placebo capsules three times per day. Zinc sulfate and placebo 
capsules were given in a double-blind manner; following three months of starting the treatment. The patients 
crossed over, i.e. patients on placebo crossed over to zinc sulfate and those on zinc sulfate crossed over to 
placebo(17), and make study for acquired zinc deficiency disease of skin, two patients, who were on long term 
parenteral hyperalimentation, developed skin lesions similar to those seen in acrodermatitis enteropathica. Both 
patients were treated with oral zinc sulphate and their skin lesions cleared completely. These patients are presented 
as an acquired zinc deficiency syndrome (18). 
   In this work atomic absorption spectrophotometer, was used for measure the concentration of zinc in serum of 
human volunteers before and after treatment with 50 mg zinc sulphate tablet, and study the others parameters which 
affect the bioavailability of zinc in human body. 
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2. Materials and Methods: 
 
        2.1  Subjects: 
     Twenty volunteers (15 males and 5 females) their ages between (24-34) years with a mean ± SD of 28.5 ± 4.94 
years, body weight between (58-84) kg with a mean ± SD of 66.90 ± 8.59 kg, and height between (160-174) cm 
with a mean ± SD of 168.5 ± 4.11 cm and Body Mass Index BMI (19) range between 0.7305±0.0759g.m-2 were 
collected from May to August 2013(Table 1). None of the subjects had a history of bone disease, peptic ulcer, 
enterectomy, regional enteritis, malabsorption, nephrolithiasis, liver cirrhosis, or renal disorder. Subjects had not 
taken zinc or vitamins, or any other drugs for the previous three months, which could affect zinc metabolism during 
the week preceding the start of the study. All study subjects were so instructed as to adhere to a daily tablet. All 
volunteers have zinc element deficiency in their blood. all volunteers took for one week a single dose of zinc 
sulphate tablet 50 mg produced by SDI which was administered orally to all volunteers who have deficiency in zinc 
levels, although the supplement of zinc tablet were taken for one week to reduce the deficiency of this element in 
their blood. Each subject appeared on the experimental day after an overnight fast. 
2.2 Apparatus:   
   Zinc concentration was determined by using Phoenx-986, flame atomic absorption spectrophotometer 
(air/acetylene flame), K-PLC Series Centrifuge, Sartorius BL 210S balance, many plastic tubes, appendorf, stick, 
stirrer sterilized before used with demonized water  and a Pentium 4 computer (DELL 1545) were used for data 
processing. 
2.3 Blood Samples: 
   About three milliliters of venous blood were collected from each subject in the study after 12 hours fast. The 
blood samples were collected in plain tubes left at Rome temperate for 15 minute then centrifuge at 3000 rpm for 
15 minute. Serum was separated and a liquated for subsequent measurement zinc level at different times 0.0, 0.5. 
1.0. 2.0, 2.0, 3.0 and 6 hours intervals of oral administration after supplementation. The experiment was repeated 
one week later with the same volunteers and given the tablets from the same batch of zinc tablets. The serum was 
analyzed by flame atomic absorption spectrophotometer.  
2.4 Analysis:  
  All samples were analyzed under stander curve which applied according to the instruction manual of 
spectrophotometer (Table2). The results were obtained from triplicate measurements. Standard solution for zinc 
covering the range of (0.25, 0.5, 1.0 and 1.5) µg.mL-1 was prepared by dilution of its stock solution (1000 µg.mL-1) 
using de-ionized distilled water. 
2.5 Data processing and Statistical analyses: 
  All obtained data were subjected to statistical analysis that was performed by using statistical software 
(STATISTICA 6.0), Stat-Soft Co. USA and Excel program office. 
 
3. Results and Discussion: 
 
3.1 Calibration graph: 
   Linear calibration graph for Zinc were obtained (Figure 1), which show that Beer's law was obey in the 
concentration range of (0.25-1.5) µ.mL-1, The regression equations, correlation coefficients, molar absorptivities, 
and sandell sensitivities in addition to other parameters are given in (Table 3). 
3.2  Accuracy and precision:    
   The accuracy and precision were confirmed by analyzing three replicate analyses of three different amounts of 
Zinc (within Beer's law) by calculating the relative error percentage and percentage relative standard deviation 
(RSD %).The results indicated good accuracies and precision at each of the studied concentration level (Table 4). 
 
3.3 Supplementation and pharmacokinetic parameters: 
  Zinc is probably the most studied of the trace elements (16). Many clinical of zinc deficiency in humans have been 
reported including (nutritional dwarfism and hypogonadism). Also, appetite and taste are adversely affected by a 
Zinc deficiency. Zinc is also an important constituent for many enzymes. The recommended daily allowance is 15 
mg/day for a male adult and 21 mg/day for lactating women (17). The results of the Zn supplementation study are 
shown in (Table 5). The results showed that the mean level of zinc in serum after treatment for one week at zero 
time was higher than the level before the treatment by about 7%. The volunteers had were recovered some of their 
deficiency form 0.6315 to 0.6775 µg.mL-1 throughout one week supplementation treatment. A simple method for 
the estimation of absorption rate constant (ka) after oral administration. The method is based on a previous work of 
Urso and Aarons known as the regression method of truncated areas for the estimation of absolute bioavailability 
for drug with a long elimination half-life. Table 6 shows the mean values of the pharmacokinetic parameters 
following oral administration of 50 mg zinc sulphate tablets SDI formula, were, absorption rate (Ka) mL.min-1, Half 
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time of absorption  (Ka 0.5t) mL.min-1,elimination rate mL.min-1 (Kelem),  Half Time of Elimination(Kelem 0.5t) 
mL.min-1, Maximum Time (T-max) mg.mL-1, Maximum Concentration(C-max) and Auc: Area Under Curve, are 
calculated (20). All calculations were done according to Traezoidal Rule (21). The results indicated that (T-max), 
which corresponds to the time, required reaching a maximum concentration (C-max) equal one hour (Figure 2). 
 
Table 1: Characteristics of the volunteers 
Subject Sex Age/years Height/cm Weight/kg BMI 
1 M 23 170 68 23.529 
2 M 24 165 65 23.875 
3 M 26 173 63 21.050 
4 M 29 166 70 25.403 
5 M 20 174 80 26.424 
6 M 35 172 78 26.366 
7 M 32 171 74 25.307 
8 M 27 167 75 26.892 
9 M 33 169 73 25.559 
10 M 29 173 84 28.066 
11 M 30 168 72 25.510 
12 M 40 174 69 22.790 
13 M 24 160 58 22.656 
14 M 23 164 57 21.193 
15 F 24 166 60 21.774 
16 F 26 168 55 19.487 
17 F 29 170 59 20.415 
18 F 30 161 60 23.148 
19 F 32 165 58 21.304 
20 F 34 165 60 24.655 
Mean - 28.5 168.05 66.90 23.770 
±SD - 4.937 4.110 8.59 2.410 
 
Table 2: Operating Parameters for FAAS 
Wave length(nm) 213.9 
Slit(nm) 0.3-0.5 
Lamp current(mA) 15 
Fuel C2H2 
Flame high(mm) 6.0 
Flame flow(mL/min) 1000 
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Figure (1): calibration curve for Zinc standard solution 
 
Table 3: Spectral characteristics and statistical data of the regression equations for determination of Zinc 
in serum 
Parameter Zn 
max (nm) λ 213.9nm 
Linearity range (mg/L) 0.25-1.5 
Molar absorpitivites 
(l.mol-1.cm-1) 76.22957 
Regression equation A = 0.1108 [ Pb(µg.mL-1)] +0.0015 
Calibration Sensitivity 0.1108 
Sandell's Sensitivity (µg.cm-2) 0.0253 
Correlation of Linearity (R2) 0.9993 
Correlation coefficient  (R) 0.9996 
 
Table 4: Evaluation the accuracy and precision of the method 
Zinc Conc. (µg.mL-1) Rel. Error % R.S.D % Taken Found* 
0.5 0.496 -0.800 1.417 
1.0 1.011 +1.100 1.347 
1.5 1.507 +0.467 1.311 
*Average of three determinations. 
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Table 5: Mean serum concentration of Zinc (µg.mL-1) with time after oral administered of 50 mg Zinc 
sulphate tablets to 20 volunteers which have deficiency of zinc element in their bodies.  
No. 
Before 
Treatment 
(Time/Hours) 
After Treatment (Time/Hours) 
0.00 0.50 1.00 2.00 3.00 6.00 
1 0.65 0.70 0.83 0.92 0.88 0.83 0.76 
2 0.64 0.68 0.80 0.90 0.85 0.80 0.73 
3 0.55 0.67 0.71 0.82 0.75 0.69 0.63 
4 0.62 0.69 0.74 0.85 0.79 0.73 0.64 
5 0.57 0.68 0.75 0.87 0.83 0.78 0.70 
6 0.55 0.64 0.72 0.81 0.75 0.69 0.66 
7 0.53 0.68 0.76 0.87 0.84 0.79 0.73 
8 0.60 0.66 0.70 0.79 0.77 0.72 0.70 
9 0.58 0.67 0.73 0.84 0.81 0.77 0.71 
10 0.63 0.75 0.81 0.94 0.90 0.86 0.81 
11 0.50 0.59 0.67 0.78 0.77 0.73 0.69 
12 0.50 0.63 0.69 0.81 0.80 0.78 0.56 
13 0.60 0.73 0.80 0.92 0.90 0.87 0.82 
14 0.62 0.72 0.78 0.91 0.88 0.86 0.80 
15 0.59 0.62 0.71 0.83 0.82 0.78 0.75 
16 0.62 0.67 0.73 0.85 0.83 0.80 0.77 
17 0.57 0.60 0.69 0.79 0.77 0.76 0.73 
18 0.66 0.69 0.78 0.91 0.90 0.87 0.85 
19 0.58 0.65 0.75 0.89 0.86 0.84 0.80 
20 0.56 0.63 0.72 0.86 0.85 0.81 0.77 
Mean 0.5860 0.6675 0.7435 0.858 0.8275 0.7880 0.7305 
±SD 0.0436 0.0430 0.0393 0.0481 0.0511 0.0588 0.0759 
 
Table 6: Pharmacokinetic parameters of Zinc sulphate(50mg tablet) after oral  administered to 20 
volunteers which have deficiency of zinc element in their bodies 
No. 
 
Ka 
ml/min 
Ka 0.5t 
ml/min 
Kelem 
ml/min 
Kelem 0.5t 
ml/min 
Tmax 
hour 
Cmax 
mg/ml 
AUC 
 
1 0.341 2.034 0.039 17.718 1 0.88 4.985 
2 0.325 2.136 0.041 17.065 1 0.85 4.776 
3 0.116 5.974 0.045 15.579 1 0.75 4.289 
4 0.140 4.952 0.057 12.285 1 0.79 4.677 
5 0.196 3.536 0.046 15.180 1 0.83 4.638 
6 0.236 2.941 0.025 27.536 1 0.75 4.248 
7 0.246 2.816 0.046 15.000 1 0.84 4.362 
8 0.263 2.634 0.046 15.164 1 0.77 4.821 
9 0.176 3.938 0.037 18.780 1 0.81 4.317 
10 0.154 4.501 0.028 24.972 1 0.90 5.133 
11 0.254 2.725 0.028 24.937 1 0.77 4.333 
12 0.246 2.817 0.042 16.422 1 0.80 4.658 
13 0.198 3.500 0.037 18.579 1 0.90 4.472 
14 0.216 3.208 0.040 17.412 1 0.88 4.832 
15 0.271 2.555 0.021 33.426 1 0.82 4.638 
16 0.172 4.039 0.019 36.603 1 0.83 4.755 
17 0.153 4.523 0.044 15.894 1 0.77 4.633 
18 0.188 3.686 0.027 25.858 1 0.90 4.962 
19 0.278 2.491 0.039 17.953 1 0.86 4.225 
20 0.267 2.594 0.025 27.709 1 0.85 4.787 
Mean 0.2218 3.3800 0.0366 20.7036 - 0.8275 4.6271 
±SD 0.0504 0.9762 0.0106 6.9858 - 0.0511 0.2630 
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Fig 2: Mean serum concentration-time profile of Zinc (µg.mL-1) after one week of continues 
supplementation a single dose of 50 mg Zinc sulphate tablet through 6 hours to 20 healthy volunteers 
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